Evaluation of Serum Bladder Cancer Specific Nuclear Matrix Proteins - 1 levels in Non-Muscle Invasive Bladder Cancer Patients.

IMMUNOCHEMICAL IDENTIFICATION OF AN EPITHELIAL MEMBRANE ANTIGEN IN PATIENTS WITH BLADDER CANCER

Evaluation of nuclear matrix protein 22 (nmp22) as urinary marker for bladder cancer

Combining nuclear matrix protein-52, collagen III, and matrix metalloproteinase-1 for more effective breast cancer early detection

Immunohistochemical expression of matrix metalloproteinase-9 in urothelial carcinoma of urinary bladder

Prospective clinical study onthe value of nuclear matrixprotein (NMP22) as a urinarytumor marker in the diagnosisand follow up of patients withbladder cancer

Telomerase Reverse Transcriptase and miR-34a in diagnosis of non-muscle invasive bladder cancer

VALUE OF BIOCHEMICAL URINARY MARKERS IN DIAGNOSIS AND PROGNOSIS OF BLADDER CANCER PATIENTS

Cytokeratin 5/6 Phenotypic Expression in Urothelial Bladder Carcinoma: Relation to Clinicopathological Parameters, FAP and CD147 Immunohistochemical Expression

MMP‐2 and MMP‐9 as prognostic markers for the early detection of urinary bladder cancer